Published Technical Disclosure Archive

Synergistic Glaucoma Treatment System using AI, IoT, and Blockchain

Publication ID: 24-11857463_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Glaucoma Treatment System using AI, IoT, and Blockchain,” Published Technical Disclosure No. 24-11857463_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857463_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,463.

Summary of the Inventive Concept

A novel system integrating visible and infrared ultrashort laser pulses with AI, IoT, and blockchain technologies to enhance glaucoma treatment outcomes and patient care.

Background and Problem Solved

The original patent disclosed methods for treating glaucoma using visible and infrared ultrashort laser pulses. However, these methods lacked the precision and personalization enabled by modern technologies. The new inventive concept addresses these limitations by incorporating AI-driven analysis, IoT-enabled real-time monitoring, and blockchain-based data storage to create a more effective and efficient glaucoma treatment system.

Detailed Description of the Inventive Concept

The Synergistic Glaucoma Treatment System consists of a laser device emitting visible and infrared ultrashort laser pulses, a fiberoptic delivery system, an AI module analyzing OCT images to guide the fiberoptic delivery system, IoT-enabled sensors for real-time monitoring, and a blockchain-based data storage system for tracking treatment outcomes and patient data. The AI module enables precise targeting of outflow obstructing tissues, while the IoT-enabled sensors provide real-time feedback for treatment optimization. The blockchain-based data storage system ensures secure and transparent tracking of patient data and treatment outcomes.

Novelty and Inventive Step

The new inventive concept introduces the novel combination of AI-driven analysis, IoT-enabled real-time monitoring, and blockchain-based data storage with visible and infrared ultrashort laser pulses, providing a significant improvement over the original patent's methods. The inventive step lies in the synergistic integration of these technologies to create a more effective, efficient, and personalized glaucoma treatment system.

Alternative Embodiments and Variations

Alternative embodiments of the Synergistic Glaucoma Treatment System could include the use of different AI algorithms, various IoT-enabled sensor configurations, or alternative blockchain-based data storage systems. Additionally, the system could be adapted for use in other ophthalmic treatments or integrated with other medical technologies.

Potential Commercial Applications and Market

The Synergistic Glaucoma Treatment System has significant commercial potential in the ophthalmic industry, particularly in the areas of glaucoma treatment and patient care. The system's ability to provide personalized, real-time treatment optimization and secure data tracking makes it an attractive solution for healthcare providers and patients alike.

CPC Classifications

SectionClassGroup
A A61 A61F9/00825
A A61 A61F9/009
A A61 A61F9/0084
A A61 A61F2009/00851
A A61 A61F2009/00865
A A61 A61F2009/00868
A A61 A61F2009/00891
A A61 A61F2009/00897

Field of Art

Ophthalmic surgical technologies, specifically laser-based interventions for glaucoma treatment, involving precision optical systems, laser pulse technologies, and minimally invasive surgical techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or ophthalmological surgical specialist with advanced training in laser technologies, optical coherence imaging, minimally invasive surgical techniques, and digital health integration strategies

Obviousness Rationale

A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies with existing laser-based glaucoma treatment methods represents a predictable technological evolution. The source patent establishes a foundational laser-based approach for trabecular meshwork intervention, which naturally invites computational and data management enhancements. The proposed technical variations represent logical extensions of existing surgical technologies, utilizing well-established interdisciplinary engineering principles.

Obvious Combinations & Variations

Source Patent Element
Laser pulses directed through cornea to ablate trabecular meshwork
PTD Variation
AI-guided fiberoptic delivery system using OCT image analysis for precise targeting
Obviousness Reasoning
Precision targeting is a known design optimization in surgical technologies, and AI-assisted guidance represents a predictable technological enhancement for improving surgical accuracy
Source Patent Element
Laser ablation of trabecular meshwork regions
PTD Variation
IoT-enabled real-time monitoring and treatment parameter adjustment
Obviousness Reasoning
Integrating sensor-based feedback for surgical procedures is a standard engineering approach for improving procedural outcomes and represents an obvious technological progression
Source Patent Element
Transcorneal photodisruption techniques
PTD Variation
Blockchain-based patient data tracking and treatment outcome documentation
Obviousness Reasoning
Secure digital record-keeping is a well-established method for medical procedure documentation, representing a straightforward technological integration
Source Patent Element
Laser-based glaucoma intervention method
PTD Variation
3D-printed customized eye implants based on patient-specific data
Obviousness Reasoning
Personalized medical device fabrication is a known technique in biomedical engineering, representing a predictable application of additive manufacturing technologies
Source Patent Element
Ophthalmic surgical laser intervention
PTD Variation
Machine learning algorithms for identifying optimal treatment parameters
Obviousness Reasoning
Computational optimization of medical procedures is a standard engineering approach, representing an obvious extension of existing technological capabilities
35 U.S.C. § 103 Summary: Based on US Patent 11857463's foundational laser-based glaucoma treatment method, the present publication demonstrates that a person of ordinary skill in the art would find the proposed technological variations obvious and predictable. The integration of AI, IoT, blockchain, and machine learning with established laser surgical techniques represents a logical and non-inventive technological progression that would be readily conceived by a skilled practitioner in the field of ophthalmic surgical technologies.

Original Patent Information

Patent NumberUS 11,857,463
TitleMethods for the treatment of glaucoma using visible and infrared ultrashort laser pulses